university of texas m d anderson cancer center

(University of Texas M. D. Anderson Cancer Center) A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports.

(University of Texas M. D. Anderson Cancer Center) When SUMO grips STAT5, a protein that activates genes, it blocks the healthy embryonic development of immune B cells and T cells unless its nemesis breaks the hold, a research team led by scientists at the University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

(University of Texas M. D. Anderson Cancer Center) Chronic inflammation combines with DNA methylation, a process that shuts down cancer-fighting genes, to promote development of colorectal cancer, scientists at The University of Texas MD Anderson Cancer Center report today in the advance online publication of the journal Nature Medicine.

(University of Texas M. D. Anderson Cancer Center) A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from the University of Texas MD Anderson Cancer Center report at the 53rd Annual Meeting of the American Society of Hematology.

(University of Texas M. D. Anderson Cancer Center) Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at the University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.

(University of Texas M. D. Anderson Cancer Center) A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting of the American Society of Hematology.

(University of Texas M. D. Anderson Cancer Center) Academic and government leaders announced today the establishment of a major new research institute at the University of Texas MD Anderson Cancer Center that will blend the best attributes of academic and industrial research to identify and validate new cancer targets, convert such scientific knowledge into new cancer drugs, and advance these novel agents into innovative clinical trials.

(University of Texas M. D. Anderson Cancer Center) When given alongside radiation therapy for head and neck cancer, acupuncture has shown for the first time to reduce the debilitating side effect of xerostomia, according to new research from the University of Texas MD Anderson Cancer Center and Fudan University Shanghai Cancer Center.

(University of Texas M. D. Anderson Cancer Center) The embryonic enzyme pyruvate kinase M2 (PKM2) has a well-established role in metabolism and is highly expressed in human cancers.

Now, a team led by researchers at the University of Texas MD Anderson Cancer Center reports in advance online publication of the journal Nature that PKM2 has important non-metabolic functions in cancer formation.

(University of Texas M. D. Anderson Cancer Center) Prostate cancer survivors and their partners experience improved sexual satisfaction and function after couples counseling, according to research at the University of Texas MD Anderson Cancer Center.

The article, published in the September issue of Cancer, a journal of the American Cancer Society, revealed both internet-based sexual counseling and traditional sex therapy are equally effective in improving sexual outcomes.

Couples on a waiting list for counseling did not improve.